News
14
2015-04
BrosMed Announces CE Mark and Launch for Minerva™ Balloon Dilatation Catheter
April 14, 2015—BrosMed announced the CE Mark and launch of its Minerva™ percutaneous transluminal angioplasty (PTA) dilatation catheter for the treatment of patients with peripheral arterial disease.
2015-04-14
27
2014-12
On December 16th, 2014, Mr. Benny Lee, GM of BrosMed Medical, and Mr. Stephen Lee, Deputy GM of BrosMed Medical, held an effective and productive meeting with Mr. Bas van’t Wout, Member of the Dutch Parliament and Vice Minister of Health, accompanied by Mr. Jos de Korte, GM of BrosMed B.V.
2014-12-27
08
2014-10
October 8, 2014— Following the FDA approval of Artimes™ Balloon Dilatation Catheter in September, BrosMed announced FDA 510(k) clearance for Apollo™ Balloon Dilatation Catheter which is now approved and ready for sale in the United States of America and the North American market for the interventional cardiovascular use.
2014-10-08
17
2014-09
September 17, 2014— Following the CE approval and launch Artimes™ Balloon Dilatation Catheter, BrosMed announced FDA 510(k) clearance for Artimes™ Balloon Dilatation Catheter which is now approved and ready for sale in the United States of America and the North America market for the interventional cardiovascular use.
2014-09-17
02
2014-09
BrosMed Establishes Europe Subsidiary in the Netherlands
September 2, 2014, BrosMed Medical has announced the establishment of a subsidiary company in the Netherlands, BrosMed Medical B.V.
2014-09-02
10
2014-07
July, 10, 2014— Following the CE approval and launch Artimes™ and Apollo™ Balloon Dilatation Catheter, BrosMed announced CE Mark and Launch of Fourteen (14) types of interventional accessories which are now approved in EU for the cardiology and radiology procedures.
2014-07-10
25
2014-02
BrosMed Announces CE Mark and Launch for Apollo™ Balloon Dilatation Catheter
February 25, 2014— Following the CE approval and launch Artimes™ Balloon Dilatation Catheter, BrosMed announced CE Mark and Launch of its Apollo™ Balloon Dilatation Catheter which is now approved in the EU for the interventional cardiovascular use.
2014-02-25
21
2013-10
BrosMed Announces CE Mark and Launch for Artimes™ Balloon Dilatation Catheter
October 19, 2013– BrosMed announced CE Mark and launch of its Artimes™ Balloon Dilatation Catheter, which is now approved in the EU for the purpose of improving myocardial blood flow in the localized stenotic lesion of the coronary arteries.
2013-10-21